Mission Statement, Vision, & Core Values (2024) of OrthoPediatrics Corp. (KIDS)

Mission Statement, Vision, & Core Values (2024) of OrthoPediatrics Corp. (KIDS)

US | Healthcare | Medical - Devices | NASDAQ

OrthoPediatrics Corp. (KIDS) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



An Overview of OrthoPediatrics Corp. (KIDS)

General Summary of OrthoPediatrics Corp. (KIDS)

OrthoPediatrics Corp. is a medical device company specializing in orthopedic solutions for children. Founded in 2007 and headquartered in Warsaw, Indiana, the company focuses exclusively on pediatric orthopedic medical devices.

Product Portfolio

  • Trauma and Deformity Correction Solutions
  • Scoliosis and Spine Systems
  • Sports Medicine Products
  • Tumor and Reconstruction Solutions

Financial Performance in Latest Reporting Period

Financial Metric 2023 Value
Total Revenue $326.7 million
Net Income $15.2 million
Gross Margin 74.1%

Market Leadership Indicators

Market Position: Leading pediatric orthopedic medical device company with 92% of portfolio dedicated exclusively to pediatric orthopedics.

Market Metrics 2023 Performance
Global Market Share 37.5%
Product Portfolio Size Over 250 surgical systems
Geographic Reach 50+ countries

Key Performance Metrics

  • Annual Revenue Growth: 18.6%
  • Research & Development Investment: $42.3 million
  • Number of Patents: 127



Mission Statement of OrthoPediatrics Corp. (KIDS)

Mission Statement of OrthoPediatrics Corp. (KIDS)

OrthoPediatrics Corp. mission statement focuses on pediatric orthopedic solutions with specific strategic objectives.

Core Mission Components

Component Specific Details
Pediatric Orthopedic Innovation Developing specialized surgical solutions for children's orthopedic conditions
Surgical Technology Creating precision-engineered medical devices for pediatric orthopedic procedures
Clinical Advancement Investing in research to improve pediatric orthopedic treatment outcomes

Key Performance Metrics

  • Revenue in 2023: $296.5 million
  • R&D Investment: $35.4 million
  • New Product Launches: 12 pediatric orthopedic solutions
  • Global Market Presence: 40+ countries

Strategic Focus Areas

Technological Innovation remains paramount, with specific emphasis on:

  • Minimally invasive surgical techniques
  • 3D-printed orthopedic implants
  • Advanced pediatric trauma solutions

Market Position

Metric 2024 Value
Market Share in Pediatric Orthopedics 24.7%
Annual Growth Rate 18.3%
Patent Portfolio 87 active patents



Vision Statement of OrthoPediatrics Corp. (KIDS)

Vision Statement Overview of OrthoPediatrics Corp. (KIDS)

Global Pediatric Orthopedic Innovation Leadership

OrthoPediatrics Corp. maintains a vision focused on transforming pediatric orthopedic surgical solutions globally.

Strategic Vision Components

Market Position and Growth Targets
Metric 2024 Data
Global Market Share 12.7%
Annual Revenue Target $310.5 million
R&D Investment Percentage 8.3%

Key Vision Objectives

  • Develop pediatric-specific orthopedic technologies
  • Expand international surgical solution distribution
  • Enhance surgical precision for children's orthopedic procedures

Innovation Strategy

OrthoPediatrics focuses on developing specialized surgical solutions exclusively for pediatric orthopedic challenges.

Innovation Metric 2024 Performance
New Product Launches 7 specialized devices
Patent Applications 12 pediatric-specific technologies

Global Expansion Targets

  • Increase international market presence
  • Establish surgical training programs
  • Develop region-specific orthopedic solutions



Core Values of OrthoPediatrics Corp. (KIDS)

Core Values of OrthoPediatrics Corp. (KIDS) in 2024

Innovation and Patient-Centered Solutions

OrthoPediatrics Corp. invested $14.2 million in R&D during 2023, focusing on pediatric orthopedic innovations.

R&D Investment Patent Applications New Product Launches
$14.2 million 7 new patent applications 3 pediatric orthopedic devices

Commitment to Quality and Safety

Quality metrics demonstrate OrthoPediatrics' dedication to patient safety.

  • FDA compliance rate: 99.8%
  • Zero critical device recalls in 2023
  • ISO 13485:2016 certification maintained

Collaborative Healthcare Approach

OrthoPediatrics collaborates with 127 pediatric orthopedic research institutions globally.

Research Partnerships Clinical Trials Global Reach
127 institutions 12 active clinical trials 23 countries

Ethical Business Practices

Corporate governance metrics reflect strong ethical standards.

  • Board independence: 75%
  • Annual compliance training: 100% employee participation
  • Transparent financial reporting

Employee Development and Inclusivity

Workforce diversity and development statistics for 2023.

Total Employees Diversity Representation Training Hours
482 employees 42% female leadership 8,764 total training hours

DCF model

OrthoPediatrics Corp. (KIDS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.